Longer treatment with vasoactive drugs to prevent early variceal rebleeding in cirrhosis

European Journal of Gastroenterology and Hepatology

Volumn 10, Issue 12, 1998, Pages 1041-1044

  De Franchis, Roberto ^a  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

Bleeding oesophageal varices; Long term administration; Rebleeding; Sclerotherapy; Terlipressin

Indexed keywords

TERLIPRESSIN; VASOACTIVE AGENT;

DRUG EFFICACY; ESOPHAGUS VARICES BLEEDING; HYPOVOLEMIC SHOCK; LIVER CIRRHOSIS; LONG TERM CARE; PORTAL HYPERTENSION; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0032423006     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-199812000-00010     Document Type: Short Survey

References (32)

1. Graham DY, Smith JL. The course of patients after variceal hemorrhage. Gastroenterology 1981; 80:800-809.
2. Avgerinos A, Nevens F, Raptis S, Fevery J. Early administration of natural somatostatin increases the efficacy of sclerotherapy in acute bleeding oesophageal variceal episodes [Abstract]. Hepatology 1996; 24:191A.
3. Burroughs AK, McCormick PA, Hughes MD, Sprengers D, D'Heygere F, McIntyre N, et al. Randomized, double-blind placebo-controlled trial of somatostatin for variceal bleeding. Gastroenterology 1990; 99:1388-1395.
4. D'Amico G, Traina M, Vizzini G, Tinè F, Polili F, Montalbano L, et al. Terlipressin or vasopressin plus transdermal nitroglycerin in a treatment strategy for digestive bleeding in cirrhosis. A randomized clinical trial. J Hepatol 1994; 20:206-212.
5. Feu F, Ruiz del Arbol L. Banares R, Planas R, Bosch J, members of the Variceal Bleeding Study Group. Double-blind randomized controlled trial comparing terlipressin and somatostatin for acute variceal hemorrhage. Gastroenferology 1996; 111:1291-1299.
6. Silvain C, Carpentier S, Sautereau D, Czernichow B, Metreau JM, Port E, et al. Terlipressin plus transdermal nitroglycerin vs. octreotide in the control of acute bleeding from esophageal varices: a multicenter randomized trial. Hepatology 1993; 18:61-65.
7. Soderlund C, Eriksson LS. Medical and surgical treatment of acute bleeding from esophageal varices in patients with cirrhosis. Scand J Gastroenterol 1991; 26:897-908.
8. Bosch J, D'Amico G, Luca A, Garcia-Pagan JC, Feu F, Escorell A, et al. Drug therapy for variceal haemorrhage. In: Portal Hypertension, Pathophysiology and Treatment. Bosch J. Groszmann RJ (editors). Oxford: Blackwell Scientific Publications; 1994. pp. 108-123.
9. Hussey KP. Vasopressin therapy for upper gastrointestinal tract haemorrhage. Has its efficacy been proven? Arch Intern Med 1985; 145:1263-1267.
10. Valenzuela JE, Schubert T, Fogel MR, Strong RM, Levine J, Mills PR, et al. A multicenter, randomized, double-blind trial of somatostatin in the management of acute hemorrhage from esophageal varices. Hepatology 1989; 10:958-961.
11. Blei AT. Vasopressin analogs in portal hypertension; different molecules but similar questions. Hepatology 1986: 6:146-147.
12. Feu F, D'Amico G, Bosch J. The acute bleeding episode: advances in drug therapy. In: Treatments in Hepatology. Arroyo V, Bosch J, Rodes J (editors). Barcelona: Masson; SA; 1995. pp. 9-22.
13. Freeman JG, Cobden I, Lishman AH, Record CO. Controlled trial of terlipressin ('Glypressin') versus vasopressin in the early treatment of oesophageal varices. Lancet 1982; ii:66-68.
14. Walker S, Stiehl A, Raedsch R, Kommerell B. Terlipressin in bleeding esophageal varices: a placebo-controlled, double-blind study. Hepatology 1986; 6:112-115.
15. de Franchis R, Arcidiacono PG, Carpinelli L, Andreoni B, Cestari J, Brunati S. et al. Randomized controlled trial of desmopressin plus terlipressin vs. terlipressin alone for the treatment of acute variceal hemorrhage in cirrhotic patients: a multicenter, double blind study. Hepatology 1993; 18:1102-1107.
16. D'Amico G, Pagliaro L, Bosch J. The treatment of portal hypertension: a meta-analytic review. Hepatology 1995; 22:332-354.
17. Burroughs AK, Alexandrino P, Cales P, Fleig W, Grace N, Minoli G, et al. 'Sore points' - a review of the points where there was disagreement at Baveno I, and an attempt to reach consensus. In: Portal Hypertension II. Proceedings of the Second Baveno International Consensus Workshop on Definitions, Methodology and Therapeutic Strategies. de Franchis R (editor). Oxford: Blackwell Science Ltd: 1996. pp. 10-17.
18. ABPI Compendium of Data Sheets and Summaries of Product Characteristics 1996-1997 with the code of practice for the pharmaceutical industry - Glypressin. Datapharm Publications Ltd: 1996. p. 356.
19. Burroughs AK, Mezzanotte G, Phillips A, McCormick PA, McIntyre N. Cirrhotics with variceal hemorrhage: the importance of the time interval between admission and the start of analysis for survival and rebleeding rates. Hepatology 1989; 9:801-807.
20. Pagliaro L, Burroughs AK, Sorensen TIA, Lebrec D, Morabito A, D'Amico G, et al. Therapeutic controversies and randomized controlled trials (RCTs): prevention of bleeding and rebleeding in cirrhosis. Gastroenterol Intern 1989; 2:71-84.
21. De Franchis R. Developing consensus in portal hypertension. J Hepatol 1996; 25:390-394.
22. Lo G-H, Lai K-H, Huang JS. Emergency sclerotherapy vs. banding lígatíon for arresting of actively bleeding esophageal varices [Abstract]. Endoscopy 1996; 28:S50.
23. Lo G-H, Lai K-H, Cheng J-S, Hwu JH, Chang CF, Chen SM, et al. A prospective, randomized trial of sclerotherapy versus ligation in the management of bleeding esophageal varices. Hepatology 1995; 22:466-471.
24. Laine L, Cook D. Endoscopic ligation compared with sclerotherapy for treatment of esophageal variceal bleeding: a meta-analysis. Ann Intern Med 1995; 123:280-287.
25. Brunati S, Ceriani R, Curioni R, Brunelli L, Repaci G, Morini L, et al. Sclerotherapy alone vs. sclerotherapy plus terlipressin vs. sclerotherapy plus octreotide in the treatment of acute variceal haemorrhage [Abstract]. Hepatology 1996; 24:207A.
26. Fiaccadori F, Pedretti G, Biraghi M, Arcidiacono R. Terlipressin and endoscopic sclerotherapy control variceal bleeding and prevent early rebleeding in cirrhotic patients. Curr Ther Res 1993; 54:519-528.
27. Cooperative Spanish-French Group for the Treatment of Bleeding Esophageal Varices. Randomized controlled trial comparing terlipressin (TP) vs. endoscopic injection sclerotherapy (EIS) in the treatment of acute variceal bleeding and prevention of early rebleeding [Abstract]. Hepatology 1997; 26:249A.
28. Ganne-Carrie N, Hadengue A, Mathurin P, Durand F, Erlinger S. Benhamou JP, et al. Hepatorenal syndrome: long-term treatment with terlipressin as a bridge to liver transplantation. Dig Dis Sci 1996; 41:1054-1056.
29. Walker S, Kreichgauer HP, Bode JC. Terlipressin vs. somatostatin in bleeding esophageal varices: a controlled, double-blind study. Hepatology 1992; 15:1023-1030.
30. Lee FY, Tsai YT, Lai KH, Chang TJ, Malik U, Lin CY, et al. A randomized controlled study of triglycyl-vasopressin and vasopressin plus nitroglycerin in the control of acute oesophageal variceal haemorrhage. Chin J Gastroenterol 1988; 5:131-138.
31. Besson I, Ingrand P, Person B, Boutroux D, Heresbach D, Bernard P, et al. Sclerotherapy with or without octreotide for acute variceal bleeding. N Engl J Med 1995; 333:555-560.
32. Sung J, Chung S, Yung M, Lai CW, Lau JYW, Lee YT, el al. Prospective randomized study of effect of octreotide on rebleeding from oesophageal varices after endoscopic ligation. Lancet 1995; 346:1666-1668.